Gerresheimer AG
XETRA:GXI
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
74.15
110.3
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one GXI stock under the Base Case scenario is 169.21 EUR. Compared to the current market price of 74.15 EUR, Gerresheimer AG is Undervalued by 56%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Gerresheimer AG
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for GXI cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Gerresheimer AG
Balance Sheet Decomposition
Gerresheimer AG
Current Assets | 879m |
Cash & Short-Term Investments | 113.9m |
Receivables | 391.4m |
Other Current Assets | 373.7m |
Non-Current Assets | 2.7B |
Long-Term Investments | 43.2m |
PP&E | 1.3B |
Intangibles | 1.2B |
Other Non-Current Assets | 24.4m |
Current Liabilities | 1B |
Accounts Payable | 297.7m |
Accrued Liabilities | 13.2m |
Other Current Liabilities | 704.6m |
Non-Current Liabilities | 1B |
Long-Term Debt | 656m |
Other Non-Current Liabilities | 393.7m |
Earnings Waterfall
Gerresheimer AG
Revenue
|
2B
EUR
|
Cost of Revenue
|
-1.4B
EUR
|
Gross Profit
|
587.4m
EUR
|
Operating Expenses
|
-377.2m
EUR
|
Operating Income
|
210.2m
EUR
|
Other Expenses
|
-95.1m
EUR
|
Net Income
|
115.1m
EUR
|
Free Cash Flow Analysis
Gerresheimer AG
EUR | |
Free Cash Flow | EUR |
In the third quarter, the company reported a modest revenue increase to EUR 499 million, with organic growth of 2.6%. Adjusted EBITDA and EPS rose to EUR 104 million and EUR 1.16, respectively. However, challenges in the Primary Packaging Glass segment saw a revenue decline of 3%. Significant factors affecting performance included ongoing customer destocking and production halts at the Morganton facility due to Hurricane Helene. Looking ahead, the company anticipates organic revenue growth between 3%-4% for 2024 and 7%-10% for 2025, with EBITDA expected between EUR 415 million and EUR 430 million, reflecting a more cautious outlook for market recovery.
What is Earnings Call?
GXI Profitability Score
Profitability Due Diligence
Gerresheimer AG's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Score
Gerresheimer AG's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
GXI Solvency Score
Solvency Due Diligence
Gerresheimer AG's solvency score is 40/100. The higher the solvency score, the more solvent the company is.
Score
Gerresheimer AG's solvency score is 40/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
GXI Price Targets Summary
Gerresheimer AG
According to Wall Street analysts, the average 1-year price target for GXI is 114.24 EUR with a low forecast of 87.87 EUR and a high forecast of 157.5 EUR.
Dividends
Current shareholder yield for GXI is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Gerresheimer AG manufactures and supplies glass and plastic products for the pharmaceutical and healthcare industry. The company is headquartered in Dusseldorf, Nordrhein-Westfalen and currently employs 10,625 full-time employees. The company went IPO on 2007-06-11. The company operates through two business segments: Plastics and Devices, and Primary Packaging Glass. The Plastics and Devices segment produces standard and customized products for drug delivery, such as insulin pens, inhalers, and prefillable syrings. The Primary Packaging Glass segment focuses on the production of packaging of glass for medicines and cosmetics, such as pharmaceuticals jars, ampoules, injection vials, cartridges, perfume flacons and cream jars, as well as glass containers for the food and beverage industry. The firm operates approximately 40 production facilities in Europe, North America, South America and Asia.
Contact
IPO
Employees
Officers
The intrinsic value of one GXI stock under the Base Case scenario is 169.21 EUR.
Compared to the current market price of 74.15 EUR, Gerresheimer AG is Undervalued by 56%.